Bayer’s “Next Wave” Of Products Will Reach Phase III Beachhead By 2015
This article was originally published in The Pink Sheet Daily
Executive Summary
In an interview, Bayer HealthCare’s recently-arrived new chief executive Olivier Brandicourt discusses the five assets that most excite the firm.